Search results for "Antineoplastic drug"

showing 10 items of 11 documents

Cisplatin preparation error; patient management and morbidity

2009

Introduction. Antineoplastic drug therapy errors represent a high iatrogenic potential due to antineoplastic drugs narrow therapeutic ranges and the complexity of chemotherapy regimens that may increase the risk of morbidity and mortality for oncology patients.Setting. We report a 57-year-old man with head and neck cancer who mistakenly received 180 mg/ m2of cisplatin overdose despite the safety measures and validations carried out during preparation. The patient developed moderate nausea and vomiting, acute renal failure, hearing difficulty (tinnitus), and severe myelodepression.Patient management. Prophylactic and symptomatic treatments were applied in order to prevent and correct toxicit…

AdultMalemedicine.medical_specialtyNauseaDrug CompoundingAntineoplastic drugmedicine.medical_treatmentAntineoplastic AgentsDrug overdoseMedication errorTinnitusmedicineHumansPharmacology (medical)Intensive care medicineBone Marrow DiseasesCisplatinChemotherapyMedical Errorsbusiness.industryNauseaAcute Kidney Injurymedicine.diseasePatient managementSurgeryOncologyHead and Neck NeoplasmsAntineoplastic DrugsCisplatinDrug Overdosemedicine.symptombusinessmedicine.drugJournal of Oncology Pharmacy Practice
researchProduct

Early detection of myocardial damage: A multimodality approach

2019

Cardiovascular diseases are possible complications of antineoplastic treatment and may lead to premature morbidity and mortality among cancer survivors. A symptom-based follow-up is ineffective, and there are growing evidences that early detection of myocardial damage in patients treated with antineoplastic drugs is the key point to prevent the occurrence of damage and improve the prognosis of these patients. Different techniques have been proposed to monitor cardiac function in oncologic patients such as cardiac imaging (echocardiography, nuclear imaging, and cardiac magnetic resonance) and biomarkers (troponin and natriuretic peptides). The European Association of Cardiovascular Imaging/A…

Cardiac function curvemedicine.medical_specialtyCardiotoxicitybiologydeformation imagingbusiness.industryEarly detectionCancermultimodality approachReview Articlemedicine.diseaseTroponinCardiotoxicityInternal medicineAntineoplastic DrugsmedicineCardiologybiology.proteinechocardiographyRadiology Nuclear Medicine and imagingIn patientearly detectionCardiology and Cardiovascular MedicinebusinessCardiac imagingJournal of Cardiovascular Echography
researchProduct

From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: A translational overview

2019

Significance: Antineoplastic therapies have significantly improved the prognosis of oncology patients. However, these treatments can bring to a higher incidence of side-effects, including the worrying cardiovascular toxicity (CTX). Recent Advances: Substantial evidence indicates multiple mechanisms of CTX, with redox mechanisms playing a key role. Recent data singled out mitochondria as key targets for antineoplastic drug-induced CTX; understanding the underlying mechanisms is, therefore, crucial for effective cardioprotection, without compromising the efficacy of anti-cancer treatments. Critical Issues: CTX can occur within a few days or many years after treatment. Type I CTX is associated…

Cardiovascular toxicityPhysiologymedicine.medical_treatmentAntineoplastic drugClinical BiochemistryAntineoplastic Agents030204 cardiovascular system & hematologyPharmacologyBiochemistryCardiac cellcancer immunotherapy; chemotherapy; ErbB2 inhibitors; oxidative/nitrosative stress; tyrosine kinase inhibitors; vascular endothelial growth factor; Antineoplastic Agents; Cardiotoxicity; Humans; Mitochondria; Oxidation-Reduction03 medical and health scienceschemistry.chemical_compoundErbB2 inhibitors cancer immunotherapy chemotherapy oxidative/nitrosative stress tyrosine kinase inhibitors vascular endothelial growth factor0302 clinical medicinetyrosine kinase inhibitorcancer immunotherapy; chemotherapy; ErbB2 inhibitors; oxidative/nitrosative stress; tyrosine kinase inhibitors; vascular endothelial growth factorChemotherapy; ErbB2 inhibitors; vascular endothelial growth factor; tyrosine kinase inhibitors; oxidative/nitrosative stress; cancer immunotherapyCancer immunotherapytyrosine kinase inhibitorsmedicineHumansChemotherapyMolecular BiologyGeneral Environmental ScienceCardioprotectionComprehensive Invited ReviewsChemotherapyErbB2 inhibitorcancer immunotherapyvascular endothelial growth factorbusiness.industryCell BiologyCardiotoxicityMitochondriaVascular endothelial growth factoroxidative/nitrosative streErbB2 inhibitorschemistry030220 oncology & carcinogenesisGeneral Earth and Planetary SciencesbusinessOxidation-ReductionAfter treatmentoxidative/nitrosative stress
researchProduct

Cardiovascular Damage Induced by Radiotherapy

2018

Radiotherapy is a fundamental therapeutic aid that in recent years has contributed significantly to improve the prognosis of cancer patients. Despite its great effectiveness, it can cause a wide spectrum of toxic effects. Among these, cardiovascular toxicity is very relevant, and it can occur even many years after the termination of treatment. The concomitant use of radiotherapy with other antineoplastic drugs, including new-generation tyrosine-kinase inhibitors or immunotherapy, can enhance its cardiotoxic effects. It is fundamental to know the cardiovascular toxic effects that are potentially linked to radiotherapy (RIHD: radiation-induced heart damage), to monitor patients who underwent …

Cardiovascular toxicitymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCancer030204 cardiovascular system & hematologymedicine.diseaseRadiation therapy03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisConcomitantmedicineAntineoplastic DrugsIntensive care medicinebusinessHeart damage
researchProduct

A preclinical model for skin sensitization prediction of antineoplasic drugs.

2020

e15643 Background: Skin side effects are common manifestations of antineoplastic drugs that are frequently observed in early clinical trials. Therefore, there is a need to identify skin toxic agents before clinical development in order to predict severe skin manifestations. In many cases, skin toxicity is due to sensitization, a key immunologic process mediating redness, swelling and itching that can lead to more severe skin alterations. Methods: We adapted three skin cellular in vitro techniques for cutaneous drug sensitization assessment of the Organization for Economic Cooperation and Development (OECD, 2012) in order to predict antineoplastic drug skin sensitization: 1) Direct peptide …

Clinical trialCancer ResearchOncologybusiness.industrySkin sensitizationAntineoplastic DrugsMedicinePharmacologybusinessJournal of Clinical Oncology
researchProduct

Peripheral olfactory function in rats after chemotherapeutic treatment with the anticancer drug docetaxel

2008

International audience; Clinical studies have documented that chemotherapeutic cancer treatment in humans is often associated with weight loss and decreased enjoyment of food. Beside taste, olfaction plays a role in the food intake regulation. We assessed whether hemotherapeutic cancer treatment compromises olfactory function in rats treated with docetaxel (Taxotere, TAX), an antineoplastic drug which disrupts the structures necessary for cell survival and division. Electroolfactogram responses (EOG) can indicate morpho-pathological changes in olfactory epithelium. Male rats received either a single, two or three intravenous injections (one per week) of an estimated 10% lethal dose (LD10) o…

DOCETAXELWEIGHT LOSS[CHIM.OTHE] Chemical Sciences/OtherANTINEOPLASTIC DRUGOLFACTIONRATCELL SURVIVALTREATMENT[CHIM.OTHE]Chemical Sciences/OtherCELL DIVISION
researchProduct

Blood flow and oxygenation status of human tumors. Clinical investigations.

1999

There is a large body of evidence suggesting that blood flow and oxygenation of human tumors are important research topics which may explain, in particular, resistance to radiation and to many antineoplastic drugs, which can limit the curability of solid tumors by radiotherapy and chemotherapy.This manuscript reviews the clinical investigations which have been performed regarding blood flow and oxygenation status of human tumors in radiation oncology.The possible uses and limitations of the prognostic significance and the changes under therapy measuring blood flow and oxygenation in human tumors were discussed. In addition, several approaches were summarized, which can improve the microvasc…

OncologyMalemedicine.medical_specialtyPathologymedicine.medical_treatmentCancer therapyHemodynamicsPilot ProjectsDrug resistanceMedical OncologyMicrocirculationInternal medicineNeoplasmsmedicineLaser-Doppler FlowmetryAnimalsHumansRadiology Nuclear Medicine and imagingUltrasonography Doppler ColorClinical OncologyChemotherapybusiness.industryMicrocirculationPatient SelectionResearchGastroenterologyDose fractionationRadiotherapy DosageBlood flowOxygenationNeoplasms ExperimentalPrognosisMagnetic Resonance ImagingCell HypoxiaRatsRadiation therapyOxygenOncologyDrug Resistance NeoplasmAntineoplastic DrugsRadiation OncologySurgeryFemaleDose Fractionation RadiationVascular functionbusinessStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
researchProduct

Experimental techniques for testing the sensitivity of bladder tumours to antineoplastic drugs

1973

A number of laboratory tests can be employed to examine the sensitivity of human bladder tumour cells to various chemotherapeutic agents.-Their principles and methods, and some preliminary results, are described with special reference to certain in vitro and in vivo cytotoxicity tests and to heterotransplantation in the hamster. Satisfactory agreement has sometimes been observed between experimental results and clinical responses, but our experience is still very limited.-The employment of several such tests would probably lead to a greater degree of reliability in the laboratory assessment of the sensitivity of bladder tumours to cytotoxic drugs.

Oncologymedicine.medical_specialtyPathologyAdministration TopicalUrologyTransplantation HeterologousHuman bladderDrug ResistanceHamsterAntineoplastic AgentsBLADDER PAPILLOMAThiophenesFluorescenceCricetinaeInternal medicinemedicineAnimalsHumansGlycosidesMelphalanIn vivo cytotoxicityPodophyllotoxinCell NucleusCarcinoma Transitional Cellbusiness.industryDaunorubicinDemecolcineDNA NeoplasmCytotoxicity Tests ImmunologicMicroscopy FluorescenceUrinary Bladder NeoplasmsDoxorubicinProtein BiosynthesisAntineoplastic DrugsOxidoreductasesbusinessNeoplasm TransplantationThiotepaUrological Research
researchProduct

Hepato-gastroenterologists and oncologists are complementary in the management of digestive cancers

2011

1. Digestive oncology – a changing fieldDigestive cancer accounts for a quarter of all cancers and con-siderable knowledge of the particular features of these disordersis required for correct treatment. Digestive oncology (DO) is amajor field of activity for hepato-gastroenterologists (HGE), whoare involved at all stages, from screening to diagnosis, follow-up,tumour evaluationandpalliativetreatment.HGEhavealsorecentlybeen recruited to multidisciplinary teams, due to their consider-able competence in the management of digestive cancers. OverallDO accounts for more than 50% of all admissions to most gas-troenterology (GI) departments. In Belgium, France and Germany,HGE withspecific,recognizedco…

Pediatricsmedicine.medical_specialtyHepatologybusiness.industryAntineoplastic drugGastroenterologyMedicineEuropean populationbusinessIntensive care medicineDigestive cancerDigestive and Liver Disease
researchProduct

Environmental and Product Contamination during the Preparation of Antineoplastic Drugs with Robotic Systems

2018

Abstract Background Robotic systems are designed to minimize the exposure to antineoplastic drugs during automated preparation. However, contamination cannot be completely excluded. The aim of the study was to evaluate the contamination with antineoplastic drugs on the working surfaces and on the outer surface of the ready-to-use products (infusion bags and syringes) during automated preparation with different versions of a robot and manual preparation. Methods Surface contamination with platinum (Pt) and 5-fluorouracil (5-FU) was measured by wipe sampling and quantified by voltammetry for Pt and GC-MS for 5-FU. Sampling was performed on pre-defined locations in the working areas before and…

PharmacyRM1-950030226 pharmacology & pharmacygas chromatography/mass spectrometryantineoplastic drugs03 medical and health sciences0302 clinical medicineMedicinePharmacology (medical)Pharmaceutical industryPharmacologyvoltammetryChromatographybusiness.industrysurface contaminationautomated compoundingContaminationwipe samplingRobotic systems030220 oncology & carcinogenesisProduct (mathematics)Antineoplastic DrugsTherapeutics. PharmacologyGas chromatography–mass spectrometryHD9665-9675businessWipe samplingPharmaceutical Technology in Hospital Pharmacy
researchProduct